538858 — Camson Bio Technologies Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsMicro Cap

Annual income statement for Camson Bio Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2014 March 31st	2015 March 31st	2016 March 31st	R2017 March 31st	2018 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,909	2,030	621	154	193
Cost of Revenue
Gross Profit	800	963	269	77.7	116
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,749	2,023	1,002	375	265
Operating Profit	160	7.6	-381	-221	-71.6
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	127	20.9	-435	-250	-112
Provision for Income Taxes
Net Income After Taxes	132	1.12	-414	-248	-112
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	132	19.4	-394	-267	-143
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	132	19.4	-394	-297	-143
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	5.64	0.671	-13	-9.93	-4.78
Dividends per Share